Total Funding
33
8
Total FundingSeries C raised
Growth Score 33 in past quarter
-2 pts
Heat Score 8 in past quarter
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
416632
Freedom Meditech provides alternatives to existing diagnostic tools for the detection, monitoring and management of chronic diseases.
Craig H. Misrach: Founder, Chairman, and CEOPast Role: Silvergate Capital, Controller and Assistant Vice President- Keith D. Ignotz: President & Chief Operating OfficerPast Role: DiaKine Therapeutics, CEO
About the Company
Freedom Meditech is a private, growth-stage medical device company focused on the development and commercialization of first-to-market, non-invasive, ophthalmic medical devices for both chronic disease detection (ClearPath DS-120) and the management of diabetes (I-SugarX). The hallmark of their product portfolio is to provide “free and healthy”
alternatives to existing diagnostic tools on the market for the detection, monitoring and management of chronic diseases.
